Gallium
Ganite (gallium) is a small molecule pharmaceutical. Gallium was first approved as Ganite on 1991-01-17. It is used to treat positron-emission tomography in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| diagnosis | D003933 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Gallium nitrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| GANITE | Genta | N-019961 DISCN | 1991-01-17 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| ganite | New Drug Application | 2012-03-19 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| positron-emission tomography | — | D049268 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V09: Diagnostic radiopharmaceuticals
— V09H: Inflammation and infection detection
— V09HX: Other diagnostic radiopharmaceuticals for inflammation and infection detection in atc
— V09HX01: Gallium (67ga) citrate
— V09I: Tumour detection radiopharmaceuticals
— V09IX: Other diagnostic radiopharmaceuticals for tumour detection in atc
— V09IX09: Gallium (68ga) edotreotide
— V09IX14: Gallium (68ga) gozetotide
HCPCS
Code | Description |
|---|---|
| A9556 | Gallium ga-67 citrate, diagnostic, per millicurie |
| A9587 | Gallium ga-68, dotatate, diagnostic, 0.1 millicurie |
| A9593 | Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie |
| A9594 | Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie |
| C9067 | Gallium ga-68, dotatoc, diagnostic, 0.01 mci |
| J1457 | Injection, gallium nitrate, 1 mg |
Clinical
Clinical Trials
89 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 5 | 6 | — | — | 4 | 12 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 4 | 3 | — | — | — | 7 |
| Meningioma | D008579 | EFO_0003098 | D32.9 | 2 | 1 | — | — | 1 | 4 |
| Neuroblastoma | D009447 | EFO_0000621 | 3 | 2 | — | — | — | 4 | |
| Lymphoma | D008223 | C85.9 | 2 | 3 | — | — | — | 4 | |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 1 | — | — | — | 3 |
| Von hippel-lindau disease | D006623 | Q85.83 | 1 | 2 | — | — | — | 3 | |
| Thyroid neoplasms | D013964 | EFO_0003841 | 1 | 1 | — | — | 1 | 3 | |
| Medulloblastoma | D008527 | — | 1 | — | — | 1 | 2 | ||
| Carcinoid tumor | D002276 | D3A.00 | 2 | 1 | — | — | — | 2 |
Show 13 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | C80 | 4 | — | — | — | — | 4 | |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 2 | — | — | — | 1 | 3 |
| Glioblastoma | D005909 | EFO_0000515 | 1 | — | — | — | 1 | 2 | |
| Sarcoma | D012509 | 2 | — | — | — | — | 2 | ||
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | 1 | 2 |
| Central nervous system neoplasms | D016543 | 2 | — | — | — | — | 2 | ||
| Multiple endocrine neoplasia type 1 | D018761 | E31.21 | 1 | — | — | — | — | 1 | |
| Invasive hydatidiform mole | D002820 | D39.2 | 1 | — | — | — | — | 1 | |
| Urologic neoplasms | D014571 | C64-C68 | 1 | — | — | — | — | 1 | |
| Uterine cervical neoplasms | D002583 | 1 | — | — | — | — | 1 |
Show 15 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 2 | 2 |
| Glioma | D005910 | EFO_0000520 | — | — | — | — | 1 | 1 | |
| Gliosarcoma | D018316 | — | — | — | — | 1 | 1 | ||
| Acoustic neuroma | D009464 | HP_0009588 | — | — | — | — | 1 | 1 | |
| Ependymoma | D004806 | — | — | — | — | 1 | 1 | ||
| Astrocytoma | D001254 | EFO_0000271 | — | — | — | — | 1 | 1 | |
| Choroid plexus neoplasms | D016545 | EFO_0007206 | — | — | — | — | 1 | 1 | |
| Craniopharyngioma | D003397 | — | — | — | — | 1 | 1 | ||
| Oligodendroglioma | D009837 | EFO_0000631 | — | — | — | — | 1 | 1 | |
| Primitive neuroectodermal tumors | D018242 | — | — | — | — | 1 | 1 |
Show 13 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | GALLIUM |
| INN | gallium (67ga) citrate |
| Description | Ganite (gallium) is a small molecule pharmaceutical. Gallium was first approved as Ganite on 1991-01-17. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 7440-55-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201200 |
| ChEBI ID | 49631 |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 4LJK511Z86 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 24,405 documents
View more details
Safety
Black-box Warning
Black-box warning for: Ganite
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
14,735 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more